Lloyd Price
NOVEMBER 25, 2023
This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.
Lloyd Price
FEBRUARY 18, 2024
They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
MAY 6, 2023
The largest funding rounds in 2018 went to companies working on healthcare technology solutions such as Rhythm Pharmaceuticals, which raised $151 million, and Modernizing Medicine, which raised $231 million. Another challenge that Olive AI has faced is increased competition in the healthcare technology space.
Waracle
JUNE 3, 2021
Covid-19 has presented a rapid increase in mobile health app usage in the short term; however, in the long run, this situation will result in the acceleration and wider adoption of digital solutions, especially those with remote care components. Before the pandemic, technology had been largely on the back-foot in most hospitals.
Healthcare IT News - Telehealth
MAY 6, 2020
The Biofourmis armband wearable, Everion, is worn 24/7 and captures the patient’s temperature, blood oxygenation and numerous other physiologic signals to detect signs of decompensation, while the patient also reports any symptoms to their healthcare provider through a mobile app. iRhythm Technologies. Spry Health. Vivify Health.
Expert insights. Personalized for you.
67 
Let's personalize your content